We are delighted to have advised the shareholders of MC Diagnostics on their investment by ACT Genomics.
Pete Maguire, Managing Director of MC Diagnostics, commented: “It was a pleasure working with the team at Claritas Tax. Matt Hodgson and Peter Hully did a great job navigating us through the complexities of tax on this transaction, through to a successful completion. Their advice was prompt, clear and concise throughout.”
Matt Hodgson, Partner at Claritas Tax, commented: “MC Diagnostics is a truly innovative businesses and market-leaders in the design, development and manufacture of molecular diagnostics testing. Pete and the wider senior management team have done an incredible job building the business, which now has an exciting journey ahead of it working alongside ACT Genomics. Pete and the wider advisory teams at Seneca Corporate Finance and Hill Dickinson were great to work with.”
